| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/21/2004 | US6794412 Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin |
| 09/21/2004 | US6794373 Contraceptive methods using benzimidazolones |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794364 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794362 Asparagine containing elastin peptide analogs |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/21/2004 | US6794360 Using histacalin protein in the manufacture of a medicament for the treatment or prevention of allergic rhinitis |
| 09/21/2004 | US6794359 Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same |
| 09/21/2004 | US6794358 Binds urokinase plasminogen activator receptor and inhibits binding to integrin; cancer, chronic inflammation, and cell migration treatment; medical diagnosis |
| 09/21/2004 | US6794357 Compositions for inhalation |
| 09/21/2004 | US6794192 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis |
| 09/21/2004 | US6794185 For the diagnosis, prevention, and treatment of tumors, cancer; fusion proteins |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6794161 Potassium channels and genes encoding these potassium channels |
| 09/21/2004 | US6794154 Comprises assaying a test substance for the activity of up-regulating the expression of liver-type fatty acid-binding protein (l-fabp) in animal cells; peroxisome proliferator-activated receptor agonists; |
| 09/21/2004 | US6794150 Detecting liver disorders in mammals; obtain sample, measure amount of marker, compare to control, diagnose liver disorder |
| 09/21/2004 | US6794145 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 09/21/2004 | US6794144 Using random manipulation of the non-conserved region of sh3 rt-loop; nef proteins; for research, diagnostics, therapy and drug discovery |
| 09/21/2004 | US6794139 Composition or use in the diagnosis, treatment and prevention of tumors |
| 09/21/2004 | US6794128 Methods of selecting internalizing antibodies |
| 09/21/2004 | US6794126 Oligopeptides capable of inhibiting interleukin 1 beta converting enzyme (ice) and preventing cell death; piece of ice itself inhibits ice; treating neurodegenerative disorders; liver disorders |
| 09/21/2004 | US6793928 Vaccines with an LTB adjuvant |
| 09/21/2004 | US6793925 Pseudomycin natural products |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793921 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 09/21/2004 | US6793920 Antithrombotic agent and anti-von willebrand factor monoclonal antibody |
| 09/21/2004 | US6793919 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 09/21/2004 | US6793918 Genetic engineering; insertion of adenovirus vectors into cells |
| 09/21/2004 | US6793917 Isolated or purified protein having migration activity on cells expressing ccr4 receptor |
| 09/21/2004 | US6793912 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 09/21/2004 | CA2420184C Conotoxins |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/21/2004 | CA2076226C Substituted 1-pyrimidinylacetamide compounds |
| 09/16/2004 | WO2004078992A2 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics |
| 09/16/2004 | WO2004078987A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
| 09/16/2004 | WO2004078981A1 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements |
| 09/16/2004 | WO2004078975A1 Novel protein and use thereof |
| 09/16/2004 | WO2004078974A1 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 09/16/2004 | WO2004078949A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | WO2004078947A2 Use of thyroid-stimulating hormone to induce lipolysis |
| 09/16/2004 | WO2004078946A2 Rnai arrays and methods for using the same |
| 09/16/2004 | WO2004078941A2 Modulation of gene expression using dna-rna hybrids |
| 09/16/2004 | WO2004078934A2 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | WO2004078925A2 Methods and compositions for treating and preventing neurodegenerative diseases |
| 09/16/2004 | WO2004078921A2 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 09/16/2004 | WO2004078920A2 Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (kca) |
| 09/16/2004 | WO2004078918A2 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 09/16/2004 | WO2004078908A2 Alpha-keto carbonyl calpain inhibitors |
| 09/16/2004 | WO2004078786A1 Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasia |
| 09/16/2004 | WO2004078784A1 Novel gene relating to fibrotic conditions |
| 09/16/2004 | WO2004078783A2 Enzymes involved in apoptosis |
| 09/16/2004 | WO2004078780A1 Pharmaceutical composition containing l-seryl-l-leucine |
| 09/16/2004 | WO2004078779A2 Conopeptides and methods of use |
| 09/16/2004 | WO2004078778A2 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF |
| 09/16/2004 | WO2004078776A2 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 09/16/2004 | WO2004078773A1 Stabilizing proteins for use in personal care, cosmetic, and pharmaceutical products |
| 09/16/2004 | WO2004078217A1 Bone calcification promoter |
| 09/16/2004 | WO2004078214A1 Compositions for nasal absorption |
| 09/16/2004 | WO2004078208A1 MEDICINAL USE OF MIP-3α INHIBITOR AND METHOD OF SCREENING BRAIN/NERVE CELL PROTECTIVE AGENT |
| 09/16/2004 | WO2004078207A1 Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| 09/16/2004 | WO2004078202A1 Clostridial neurotoxins for treating uterine disorders |
| 09/16/2004 | WO2004078201A1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
| 09/16/2004 | WO2004078200A1 Selection of patients with increased responsiveness to botulinum toxin |
| 09/16/2004 | WO2004078199A1 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 09/16/2004 | WO2004078198A1 Long acting injectable insulin composition and methods of making and using thereof |
| 09/16/2004 | WO2004078197A1 Delivery system for drug and cell therapy |
| 09/16/2004 | WO2004078196A1 Oral insulin composition and methods of making and using thereof |
| 09/16/2004 | WO2004078195A1 Agent for converting intestinal cell into insulin-producing cell and remedy for diabetes |
| 09/16/2004 | WO2004078194A1 Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| 09/16/2004 | WO2004078193A1 Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| 09/16/2004 | WO2004078192A1 Use of tumor endothelial markers 1, 9 and 17 to promote angiogenesis |
| 09/16/2004 | WO2004078181A1 Rna interference based methods and compositions for inhibiting hbv gene expression |
| 09/16/2004 | WO2004078160A1 New process for the production of implants |
| 09/16/2004 | WO2004078147A2 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | WO2004078146A2 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | WO2004078145A2 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078135A2 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
| 09/16/2004 | WO2004078127A2 Continuous delivery methods for treating hepatitis virus infection |
| 09/16/2004 | WO2004078124A2 Methods and compositions involving mda-7 |
| 09/16/2004 | WO2004078098A2 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 09/16/2004 | WO2004078097A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | WO2004078061A2 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 09/16/2004 | WO2004067753A3 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 09/16/2004 | WO2004067027A3 Osteogenic composition |
| 09/16/2004 | WO2004067024A3 Hcv combination therapy |
| 09/16/2004 | WO2004065406A3 Rantes-derived peptides with anti-hiv activity |
| 09/16/2004 | WO2004064709A3 Thrombolytic agent |
| 09/16/2004 | WO2004062688A3 Use of cc-chemokine mutants against liver diseases |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004062556A3 Methods for preventing and treating alzheimer’s disease (ad) |
| 09/16/2004 | WO2004060393A3 Cutaneous metabolic bio-activator |
| 09/16/2004 | WO2004058798A3 Antimicrobial peptides |
| 09/16/2004 | WO2004055513A3 Use of cd137 antagonists for the treatment of tumors |
| 09/16/2004 | WO2004052916A3 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids |
| 09/16/2004 | WO2004052295A3 Compositions and methods for nutrition supplementation |